论文部分内容阅读
肝硬化的存在是否可预测干扰素治疗慢性丙型肝炎疗效,一直有争论。本研究旨在确定肝硬化是否影响干扰素疗效,其对6个或12个月疗程的初始效果及治疗结束后6个月内持续效果的影响程度如何。
Whether the presence of cirrhosis can predict the efficacy of interferon in the treatment of chronic hepatitis C has been debated. The aim of this study was to determine if cirrhosis affects the efficacy of interferon and how well it will affect the initial effect of 6 or 12 months of treatment and the sustained effect within 6 months of the end of treatment.